Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-29 Option Award | 2022-06-30 4:22 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-06-30 4:21 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-06-30 4:20 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-06-30 4:19 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-06-30 4:18 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-06-30 4:17 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-06-30 4:00 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 70,000 | $0 | 2,800,277 (Indirect) | View |
| 2022-04-26 Tax Withholding | 2022-04-28 4:31 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 282 | $9.99 | 9,328 (Direct) | View |
| 2022-04-26 Exercise | 2022-04-28 4:31 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 991 | $0 | 9,328 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-11 4:32 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 69,920 | $0 | 69,920 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-11 4:31 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 76,325 | $0 | 76,325 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-11 4:31 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 47,190 | $0 | 47,190 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-11 4:30 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 279,762 | $0 | 279,762 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-11 4:30 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 69,368 | $0 | 69,368 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-11 4:30 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 75,437 | $0 | 75,437 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 18,555 | $0 | 210,887 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 5,446 | $10.98 | 210,887 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 2,270 | $0 | 7,372 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,240 | $10.98 | 7,372 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 3,019 | $0 | 5,648 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 1,047 | $10.98 | 5,648 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 5,676 | $0 | 35,117 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 1,686 | $10.98 | 35,117 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 3,231 | $0 | 6,041 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 1,120 | $10.98 | 6,041 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 4,611 | $0 | 112,213 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 1,461 | $10.98 | 112,213 (Direct) | View |
| 2020-06-30 Option Award | 2022-03-18 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 641 | $9.51 | 6,253 (Direct) | View |
| 2020-06-30 Option Award | 2022-03-18 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 588 | $11.49 | 6,253 (Direct) | View |
| 2020-06-30 Tax Withholding | 2022-03-18 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 269 | $10.13 | 6,253 (Direct) | View |
| 2020-06-30 Option Award | 2022-03-18 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 405 | $15.02 | 6,253 (Direct) | View |
| 2020-06-30 Exercise | 2022-03-18 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 775 | $0 | 6,253 (Direct) | View |
| 2020-06-30 Option Award | 2022-03-18 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 653 | $9.63 | 6,253 (Direct) | View |
| 2021-07-15 Option Award | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer | 963 | $11.49 | 9,324 (Direct) | View |
| 2021-07-15 Tax Withholding | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer | 544 | $10.13 | 9,324 (Direct) | View |
| 2021-07-15 Exercise | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer | 995 | $0 | 9,324 (Direct) | View |
| 2021-07-15 Option Award | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer | 1,546 | $9.63 | 9,324 (Direct) | View |
| 2022-03-16 Tax Withholding | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. Chief Medical Officer | 598 | $10.13 | 36,302 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. Chief Medical Officer | 1,725 | $0 | 36,302 (Direct) | View |
| 2022-03-16 Tax Withholding | 2022-03-18 4:38 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 1,922 | $10.13 | 217,485 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:38 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 6,569 | $0 | 217,485 (Direct) | View |
| 2022-03-16 Tax Withholding | 2022-03-18 4:38 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 303 | $10.13 | 6,292 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:38 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 872 | $0 | 6,292 (Direct) | View |
| 2021-07-15 Option Award | 2022-03-18 4:36 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Operating Officer | 868 | $11.49 | 114,955 (Direct) | View |
| 2021-07-15 Tax Withholding | 2022-03-18 4:36 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Operating Officer | 681 | $10.13 | 114,955 (Direct) | View |
| 2021-07-15 Exercise | 2022-03-18 4:36 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Operating Officer | 1,964 | $0 | 114,955 (Direct) | View |
| 2021-07-15 Option Award | 2022-03-18 4:36 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Operating Officer | 970 | $9.63 | 114,955 (Direct) | View |
| 2021-10-04 Option Award | 2021-10-06 4:51 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 700 | $0 | 700 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:21 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Business Officer | 54,994 | $0 | 54,994 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:20 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 9,293 | $0 | 9,293 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:19 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Pano Arian Chief Clinical Dev. Officer | 27,213 | $0 | 27,213 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:18 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 52,105 | $0 | 52,105 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:16 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross ARCALYST General Manager | 11,931 | $0 | 11,931 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:15 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. Chief Medical Officer | 48,300 | $0 | 48,300 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:14 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 183,934 | $0 | 183,934 (Direct) | View |
| 2021-06-29 Option Award | 2021-07-01 4:08 pm | N/A 2031-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 66,474 | $0 | 66,474 (Indirect) | View |
| 2021-06-29 Option Award | 2021-06-30 4:22 pm | N/A 2031-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 33,237 | $0 | 33,237 (Direct) | View |
| 2021-06-29 Option Award | 2021-06-30 4:22 pm | N/A 2031-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 33,237 | $0 | 33,237 (Direct) | View |
| 2021-06-29 Option Award | 2021-06-30 4:21 pm | N/A 2031-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 33,237 | $0 | 33,237 (Direct) | View |
| 2021-06-29 Option Award | 2021-06-30 4:20 pm | N/A 2031-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 33,237 | $0 | 33,237 (Direct) | View |
| 2021-06-29 Option Award | 2021-06-30 4:20 pm | N/A 2031-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 33,237 | $0 | 33,237 (Direct) | View |